AstraZeneca working on vaccine to prevent and cure Covid: MD Gagandeep Singh Anglo-Swedish pharma company AstraZeneca has mobilised research efforts to advance the development of a novel coronavirus-neutralising long-acting antibody combination (LAAB) for the potential prevention and treatment of Covid-19, pharma company's India managing director Gagandeep
India considers resuming vaccine exports soon, focus on Africa, says source India, the world's biggest maker of vaccines overall, stopped vaccine exports in April to focus on inoculating its own population as infections exploded.
COVID vaccine creator says mass boosters may be unnecessary France was among the first few countries to start distributing third jabs to the elderly and people with compromised immune systems, among others. The US plans to launch a booster shot distribution campaign for all Americans with Pfizer and Moderna shots.
Nerve disorder listed as 'very rare' side effect of AstraZeneca jab Guillain-Barre Syndrome was a "very rare" side effect, occurring in under one in 10,000 people, it added. The disorder is a nerve inflammation that may cause temporary paralysis and difficulty breathing.
COVAX vaccine 2021 delivery target cut to 1.4 billion doses The head of the GAVI Vaccine Alliance, which sponsors the COVAX programme along with the World Health Organisation, Unicef and the Coalition for Epidemic Preparedness Innovations (CEPI), pleaded with rich countries to share more doses.
UK, India in 'sweet spot' as trade negotiations begin, says Britain's trade minister Both the minister and the Lord Mayor, William Russell, underlined the Enhanced Trade Partnership (ETP) agreed between Prime Ministers Narendra Modi and Boris Johnson at their virtual summit in May as setting out an ambitious roadmap to at least double bilateral trade by 2030.